AIIMS and IISER Bhopal revolutionize cancer detection with AI technology.

CNN Central News & Network–ITDC India Epress/ITDC News Bhopal: A joint team from AIIMS Bhopal and IISER Bhopal is developing a technology using deep learning and AI techniques that will automatically detect head tumors and neck cancer. This team has been selected for the TIIC Accelerator Program 2024, organized by TDK Corporation Japan and the Gopalakrishnan Deshpande Center (GDC) at IIT Madras. AIIMS Bhopal Executive Director Professor Ajay Singh expressed, “We need to turn our vision into reality to reduce the suffering of patients. Together, we aim to make a difference in patients’ lives through advanced treatments.”

This partnership will help develop modern equipment for complex patient treatments. In the future, AIIMS Bhopal could be developed as a Center of Excellence in Central India through collaborative efforts. TDK Corporation Japan and IIT Madras’ Gopalakrishnan Deshpande Center (GDC) assist startups in developing new technologies. This project will create technology that automatically detects head tumors and neck cancer, potentially revolutionizing radiotherapy by speeding up and improving the accuracy of tumor detection. This technology is not yet available anywhere in the world. As part of the project, the team will participate in an eight-week workshop at IIT Madras, where they will refine their technology and explore ways to make it commercially viable

The project is led by Dr. Rajesh Pasricha from AIIMS Bhopal’s Radiotherapy Department, with team members including Medical Physicist Avneesh Mishra, Resident Doctor Srinivas Reddy, and Dr. Arvind. The IISER Bhopal team includes Tanmay Basu, Vinod Kurmi, and Feroz Suri.

Expressing his delight over the team’s selection, AIIMS Bhopal Executive Director Ajay Singh said, “This collaboration highlights the commitment of AIIMS Bhopal and IISER Bhopal to developing new technology. AI-based solutions will enhance the precision of radiotherapy and improve treatment outcomes for patients. We are confident that this project will be a significant milestone in cancer treatment.”